Akèy › Twoub depresif majè › Kalifòni › San Diego
Etid klinik pou Twoub depresif majè nan San Diego, CA
16 etid pou Twoub depresif majè ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Ap rekriteFaz 2
- Kadima Neuropsychiatry Institute, La Jolla · 11 mi lwen
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Ap rekriteFaz 3
- Kadima Neuropsychiatry Institute, San Diego
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 2
- Artemis Institute For Clinical Research - San Diego, San Diego
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Ap rekriteFaz 4
- Neurocrine Clinical Site, San Diego
Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
Ap rekrite
- UCSD Interventional Psychiatry, San Diego
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Ap rekriteFaz 3
- Artemis Institute for Clinical Research, San Diego
- Center for Neurohealth, La Jolla · 11 mi lwen
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Ap rekriteFaz 2
- Draig Clinical Site, San Diego
Enhancing Veteran-Clinical Collaboration in VA PRRCs
Ap rekrite
- VA San Diego Healthcare System, San Diego, CA, San Diego
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Ap rekriteFaz 3
- Clinical Research Site, San Diego
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, San Diego
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
Ap rekriteFaz 2
- Kadima Neuropsychiatry Institute, La Jolla · 11 mi lwen
Mindfulness Engaged Neurostimulation for Depression (MEND II)
Ap rekriteFaz 2
- UC San Diego Health Psychiatry, San Diego
Maintenance rTMS for Depression (Maitr-De)
Ap rekrite
- University of California, San Diego, San Diego
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Ap rekriteEtid obsèvasyon
- Salma Health, La Jolla · 11 mi lwen
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Ap rekriteFaz 3
- Neurocrine Clinical Site, San Diego
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Ap rekriteFaz 4
- Clinical Research Site, San Diego
Etid Twoub depresif majè nan lòt vil
- New York City, NY36 etid
- Boston, MA31 etid
- Atlanta, GA25 etid
- Philadelphia, PA23 etid
- Orlando, FL19 etid
- Miami, FL18 etid
- Chicago, IL17 etid
- Tampa, FL17 etid
- Houston, TX16 etid
- Little Rock, AR14 etid
- Austin, TX13 etid
- Las Vegas, NV13 etid
Lòt etid nan San Diego
- Kansè Poumon ki pa ti selil48 etid
- Kansè nan tete41 etid
- Kansè (tout kalite)32 etid
- Kansè pwostat31 etid
- Kansè Metastatik30 etid
- Kansè kolorektal25 etid
- Kansè ovè24 etid
- Kansè pankreyas24 etid
- Kansè poumon23 etid
- Obèsite23 etid
- Ensifizyans kadyak23 etid
- Depresyon21 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.